Go to main contentsGo to search barGo to main menu
Wednesday, July 23, 2025 at 6:17 AM

How to Contact Legislators and Testify During a Closed Legislature

How to Contact Legislators and Testify During a Closed Legislature
File photo

Janine Hansen, director of the Nevada Families for Freedom recently spoke at the monthly meeting of the Churchill Republican Women. She spoke on several issues pending or expected to be introduced during the 81st Nevada Legislative session. 

Hansen has been involved in Nevada politics for most of her life and is a registered lobbyist. She encourages citizens to become involved in the legislative process and says officially voicing opinion by writing letters, calling representatives, and testifying during committee meetings is the most effective way to affect change. 

That process is complicated this year, due to COVID the legislature building is closed to the public and committee hearings are being held virtually. Hansen provided detailed instructions that people can use to voice their concerns and participate in the legislative process.

The State of Nevada Legislature website is located at www.leg.state.nv.us and Hansen says the first step is to know the bill number of the legislation and use that to find the committee and the meeting time. At the home page, click on “Scheduled Meetings” on the right-hand side of the top blue bar and scroll down to the specific committee and click on that. 

There will be a box on the right “participate” that will bring up a box with another “participate” button. That will take the user to the registration screen which will then go to the option to offer comment on a specific “agenda item” or “public comment.” All testimony is being limited strictly to two minutes, so Hansen recommends preparing remarks carefully. After selecting the rest of the choices, click on the “I’m not a robot” and follow the instructions before clicking “Submit.” 

An email will then be sent confirming participation and give a number to call and the meeting ID which will be required to enter. When the meeting starts there will most likely be several items on the agenda and Hansen recommends being on the call at the beginning of the meeting because the order of the items is often changed. Listen for instructions and when your turn comes, press *6 to unmute, give your name and spell it and then speak for the two-minute testimony time. 

The help line is 775-684-1300 or email [email protected]
 

 


Share
Rate

Comment

Comments

COMMENTS
Comment author: Mike HinzComment text: I knew Sam as a member of our church growing up. He always had a warm smile, a kind word, and a great sense of humor! He will be great missed!Comment publication date: 7/2/25, 11:57 AMComment source: Obituary -- Samuel Bruce WickizerComment author: Mike HinzComment text: Great teacher, great coach, but even a better person!!! Rest in peace Mr. BeachComment publication date: 7/2/25, 11:53 AMComment source: Obituary -- Jack Victor Beach, Jr.Comment author: Mike HinzComment text: I had Mrs Hedges for First Grade at Northside Elementary in 1969. I still, to this day, remember her as a wonderful teacher…one of my favorites!!Comment publication date: 7/2/25, 11:29 AMComment source: Obituary - Nancy Marie Hedges C Comment author: Carl C. HagenComment text: What are MFNs and PBMs ?? ............................ From the editor: This is a very good question and we apologize for not catching that wasn't in there. We reached out to the writer/submitter and got this info back...hope it's helpful. PBM: Pharmacy Benefit Managers are pharmacies that are owned by insurance companies. (CVS is one.) They negotiate with drug makers to get reduced pricing for medications, but they historically have not passed along those savings to patients. https://www.ftc.gov/system/files/ftc_gov/pdf/pharmacy-benefit-managers-staff-report.pdf MFN: Most Favored Nation pricing is a policy that means a country agrees to offer the same trade concessions (like tariffs or price reductions) to all member nations of the World Trade Organization (WTO). When applied to pharmaceuticals, it could disrupt global access, deter innovation, and obscure the deeper systemic issues in American health care. https://petrieflom.law.harvard.edu/2025/05/22/the-global-risks-of-americas-most-favored-nation-drug-pricing-policy/Comment publication date: 6/23/25, 7:47 AMComment source: L E T T E R TO THE EDITOR
SUPPORT OUR WORK